Picture of Windlas Biotech logo

WINDLAS Windlas Biotech News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousSmall CapHigh Flyer

Brief: Windlas Biotech Concludes EU GMP Inspection, Received Zero Critical Observations

April 14 (Reuters) - Windlas Biotech Ltd  WINL.NS :
    * CONCLUDES EU GMP INSPECTION, RECEIVED ZERO CRITICAL
OBSERVATIONS/ DEFICIENCIES

Source text for Eikon:  ID:nBSEbJDZk9 
Further company coverage:  WINL.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Windlas Biotech

See all news